Annual Meeting 2015: A review of current and future directions of clinical trials for CLL - 101793

Spotlight
Video

Annual Meeting 2015: A review of current and future directions of clinical trials for CLL

VJHemOnc has 915 videos Subscribe Here

Loading........
Description: At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center, Boston, MA, reviews the different approaches to the therapy of chronic lymphocytic leukemia (CLL) that are being studied, including a phase 1 trial of lenalidomide plus bendamustine and rituximab (BR) for untreated CLL; a phase 3 trial ibrutinib plus BR for previously treated CLL or small lymphocytic lymphoma; and a phase 3 trial of BR, rituximab and ibrutinib, or ibrutinib alone for older patients with previously untreated CLL.

—————

The Video Journal of Hematological Oncology (VJHemOnc) is an independent, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve understanding and awareness of hematological malignancies.

Website: http://www.vjhemonc.com/...
Twitter: https://twitter.com/VJHemOn...
Facebook: https://www.facebook.com/vj...
LinkedIn: https://www.linkedin.com/co...
Shared By : VJHemOnc
Posted on : 08/07/15
Added : 3 years ago



Recommended

Nothing found.

More From VJHemOnc

Nothing found.